全文获取类型
收费全文 | 975740篇 |
免费 | 71071篇 |
国内免费 | 1437篇 |
专业分类
耳鼻咽喉 | 13395篇 |
儿科学 | 26056篇 |
妇产科学 | 24455篇 |
基础医学 | 138512篇 |
口腔科学 | 28643篇 |
临床医学 | 86359篇 |
内科学 | 191249篇 |
皮肤病学 | 20121篇 |
神经病学 | 76797篇 |
特种医学 | 37688篇 |
外国民族医学 | 79篇 |
外科学 | 156791篇 |
综合类 | 18412篇 |
现状与发展 | 2篇 |
一般理论 | 319篇 |
预防医学 | 68263篇 |
眼科学 | 22064篇 |
药学 | 75723篇 |
3篇 | |
中国医学 | 2216篇 |
肿瘤学 | 61101篇 |
出版年
2021年 | 7252篇 |
2019年 | 7564篇 |
2018年 | 10716篇 |
2017年 | 8365篇 |
2016年 | 9193篇 |
2015年 | 10348篇 |
2014年 | 14105篇 |
2013年 | 20278篇 |
2012年 | 28238篇 |
2011年 | 29094篇 |
2010年 | 17028篇 |
2009年 | 16097篇 |
2008年 | 27814篇 |
2007年 | 28841篇 |
2006年 | 29406篇 |
2005年 | 28171篇 |
2004年 | 26928篇 |
2003年 | 25616篇 |
2002年 | 24885篇 |
2001年 | 54923篇 |
2000年 | 56672篇 |
1999年 | 47154篇 |
1998年 | 11012篇 |
1997年 | 9664篇 |
1996年 | 9756篇 |
1995年 | 9074篇 |
1994年 | 8384篇 |
1993年 | 7685篇 |
1992年 | 35554篇 |
1991年 | 33957篇 |
1990年 | 32780篇 |
1989年 | 31924篇 |
1988年 | 29030篇 |
1987年 | 28278篇 |
1986年 | 26316篇 |
1985年 | 25176篇 |
1984年 | 17869篇 |
1983年 | 15180篇 |
1982年 | 7810篇 |
1979年 | 15793篇 |
1978年 | 10620篇 |
1977年 | 9066篇 |
1976年 | 7889篇 |
1975年 | 8644篇 |
1974年 | 10472篇 |
1973年 | 9873篇 |
1972年 | 9367篇 |
1971年 | 8859篇 |
1970年 | 8432篇 |
1969年 | 7928篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
2.
Hannah C. Nordhues Anjali Bhagra Natya N. Stroud Jennifer A. Vencill Carol L. Kuhle 《Mayo Clinic proceedings. Mayo Clinic》2021,96(7):1907-1920
The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and health burdens along with overlapping vulnerabilities related to the pandemic. In addition, this review outlines recommended strategies that advocacy groups, community leaders, and policymakers should implement to mitigate the widening gender disparities related to COVID-19. 相似文献
3.
4.
Anela Stanic Denis Rybin Francis Cannata Carole Hohl Jennifer Brody Jessie Gaeta 《AIDS care》2021,33(1):1-9
ABSTRACT The lack of stable housing can impair access and continuity of care for patients living with human immunodeficiency virus (HIV). This study investigated the relationship between housing status assessed at multiple time points and several core HIV-related outcomes within the same group of HIV patients experiencing homelessness. Patients with consistently stable housing (CSH) during the year were compared to patients who lacked CSH (non-CSH group). The study outcomes included HIV viral load (VL), CD4 counts, and health care utilization. Multivariable and propensity weighted analyses were used to assess outcomes adjusting for potential group differences. Of 208 patients, 88 (42%) had CSH and 120 (58%) were non-CSH. Patients with CSH had significantly higher proportion of VL suppression and higher mean CD4 counts. The frequency of nurse visits in the CSH group was less than a half of that in the non-CSH group. Patients with CSH were less likely to be admitted to the medical respite facility, and if admitted, their length of stay was about a half of that for the non-CSH group. Our study findings show that patients with CSH had significantly better HIV virologic control and immune status as well as improved health care utilization. 相似文献
5.
Yuxiang Ma Wenfeng Fang Hongyun Zhao Sai Praneeth Bathena Amol Tendolkar Jennifer Sheng Li Zhang 《The oncologist》2021,26(4):e549-e566
Lessons Learned
- The overall safety profiles of ipilimumab 3 mg/kg and 10 mg/kg administered every 3 weeks, were consistent between Chinese patients with solid tumors in the current study and patients from previous U.S. ipilimumab monotherapy studies. No new safety signals were identified.
- The mean systemic exposures to ipilimumab (assessed by first dose area under the curve during the dosing interval and maximum serum concentration) were numerically lower in the Chinese patient population than in U.S. patients for both 3 mg/kg and 10 mg/kg doses; however, the range of serum concentrations in the Chinese and U.S. populations overlapped (3 mg/kg and 10 mg/kg), suggesting that ipilimumab pharmacokinetics was ethnically insensitive in this study.
6.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献
7.
BackgroundLittle is known about the extent of ordering low-value services by.PurposeTo compare the rates of low-value back images ordered by primary care physicians (PCMDs) and primary care nurse practitioners (PCNPs).MethodWe used 2012 and 2013 Medicare Part B claims for all beneficiaries in 18 hospital referral ?regions (HRRs) and a measure of low-value back imaging from Choosing Wisely. Models included random clinician effect and fixed effects for beneficiary age, disability, Elixhauser comorbidities, clinician sex, the emergency department setting, back pain visit volume, organization, and region (HRR).FindingsPCNPs (N = 231) and PCMDs (N = 4,779) order low-value back images at similar rates (NP: all images: 26.5%; MRI/CT: 8.4%; MD: all images: 24.5%; MRI/CT: 7.7%), with no detectable significant difference when controlling for covariates.DiscussionPCNPs and PCMDs order low-value back images at an effectively similar rate. 相似文献
8.
9.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
10.